US equities
|
MU
$1,084.75
▲+3.75%
NVDA
$236.85
▼-1.00%
SNDK
$1,715.96
▲+3.34%
SPCX
$166.81
▼-2.97%
AMD
$643.79
▼-0.87%
TSLA
$377.13
▼-0.93%
INTC
$112.55
▲+0.04%
AAPL
$337.11
▲+1.04%
MU
$1,084.75
▲+3.75%
NVDA
$236.85
▼-1.00%
SNDK
$1,715.96
▲+3.34%
SPCX
$166.81
▼-2.97%
AMD
$643.79
▼-0.87%
TSLA
$377.13
▼-0.93%
INTC
$112.55
▲+0.04%
AAPL
$337.11
▲+1.04%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Biotricity, Inc. - Common Stock
(NQ:
BTCY
)
0.4631
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biotricity, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
SWK Holdings Provides Portfolio Update
October 17, 2024
Via
ACCESSWIRE
Biotricity Provides Updated Guidance for Earlier than Expected Path to Profitability due to Growing Revenues and Improving Margins
October 03, 2024
Via
ACCESSWIRE
Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States
September 26, 2024
Via
ACCESSWIRE
Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals
September 19, 2024
Via
ACCESSWIRE
Biotricity Reports Continued Margin Improvement and Reduced Losses in its First Quarter Fiscal Year 2025
August 21, 2024
Via
ACCESSWIRE
BTCY Stock Earnings: Biotricity Reported Results for Q1 2025
↗
August 20, 2024
Biotricity just reported results for the first quarter of 2025.
Via
InvestorPlace
Biotricity Launches HeartSecure: Immediate, At-Home Cardiac Screening Now Available
June 28, 2024
Via
ACCESSWIRE
Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets
June 06, 2024
Via
ACCESSWIRE
LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 26, 2024
Via
ACCESSWIRE
Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud
July 22, 2024
Via
ACCESSWIRE
Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 19, 2024
Via
ACCESSWIRE
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
July 17, 2024
Via
ACCESSWIRE
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 12, 2024
Via
ACCESSWIRE
Biotricity Announces Accelerated Path to EBITDA Positive
July 11, 2024
Via
ACCESSWIRE
Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program
July 10, 2024
Via
ACCESSWIRE
BTCY Stock Earnings: Biotricity Beats EPS, Misses Revenue for Q4 2024
↗
June 27, 2024
BTCY stock results show that Biotricity beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via
InvestorPlace
Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Company's Path to Profitability
June 27, 2024
Via
ACCESSWIRE
Biotricity to Host Fourth Quarter and Fiscal Year 2024 Financial Results and Business Update Call on June 27
June 26, 2024
Via
ACCESSWIRE
Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the #1 Global Killer, Poising Company to Access the Growing Home Diagnostics Market
June 12, 2024
Via
ACCESSWIRE
Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock
June 04, 2024
Via
ACCESSWIRE
Biotricity Announces the Upcoming Launch of the First-Ever Direct-to-Patient Cardiac Screening Service, Targeting the $1.05B Home Heart Health Market
May 30, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 16, 2024
Via
Benzinga
Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companies
April 30, 2024
Via
ACCESSWIRE
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
April 26, 2024
Via
ACCESSWIRE
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
April 18, 2024
Via
ACCESSWIRE
Biotricity Launches Cardiac Monitoring Pilot Program with Major Hospital Network
April 16, 2024
Via
ACCESSWIRE
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
April 15, 2024
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...
Via
Benzinga
Biotricity Announces a Strategic Partnership for Cardiac Screenings in Patients with Co-Morbidities
April 02, 2024
Via
ACCESSWIRE
LOBO EV and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
March 28, 2024
Via
ACCESSWIRE
Biotricity Accelerates Market Access by Partnering with Third Major Group Purchasing Organization, Expanding Market Reach to 90% of U.S. Hospitals
March 28, 2024
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
Next >
